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Purpose: To evaluate the effect of phacoemulsiﬁcation on intraocular pressure (IOP) in pseudoexfoliation (PEX) syndrome and its diurnal
variation.
Methods: In this prospective, non-comparative, interventional case series, phacoemulsiﬁcation was done for patients with PEX and concomitant
visually signiﬁcant cataract. Follow-up examinations including IOP measurement were done at postoperative day 1, week 1, month 1, month 3,
and month 6. All IOP measurements were performed twice daily: once in the morning between 8 and 10 AM and the other in the evening
between 6 and 8 PM. The minimum and maximum IOP and the mean IOP were recorded. IOP variation was deﬁned as the difference between
maximum and minimum pressures.
Results: Sixty-eight eyes of 68 patients were analyzed. The mean IOP dropped from 17.45 7 3.32 mm Hg to 12.57 7 1.58 mm Hg at
6 months. The minimum and maximum IOP dropped from 14.97 7 3.46 mm Hg and 20.03 7 3.39 to 11.53 7 1.79 mm Hg and 13.01 7 1.81
after 6 months, respectively. Diurnal IOP variation dropped from 5.06 7 1.85 mm Hg (range 2–10) at baseline to 1.49 7 0.93 mm Hg (range 0–
4) at postoperative month 6 (p o 0.001 for all). This drop was not correlated with age and CCT, but was strongly correlated with baseline IOP
variation (r = 0.847, p o 0.001).
Conclusion: Phacoemulsiﬁcation without any additional intervention can be an attractive choice in managing the IOP and its diurnal variations in
pseudoexfoliation patients, even with elevated IOP, who do not have advanced optic nerve damage.
& 2015 Iranian Society of Opthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Pseudoexfoliation (PEX) syndrome is an age-related sys-
temic disease, with primarily ophthalmic manifestations. It is
characterized by accumulation of abnormal extracellular ﬁbril-
lary material on pupillary border, lens capsule, angle, and other
tissues of the body.1–3 Cataract and glaucoma are two main
complications of the disease. In fact, PEX is the most common/10.1016/j.joco.2015.09.006
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baseline intraocular pressure (IOP) and high diurnal IOP
ﬂuctuation even in normotensive eyes with PEX are consid-
ered major risk factors for the development and progression of
glaucoma.8,9 Although the beneﬁcial effect of cataract surgery
on IOP drop in PEX patients has been reported in previous
studies,10–12 few studies have analyzed its effect on minimum
and maximum IOP, and especially its diurnal variations in
PEX patients.
The aim of this study was to evaluate the role of
phacoemulsiﬁcation on IOP changes and its diurnal variations
in pseudoexfoliative eyes with concomitant visually signiﬁcant
cataract (Fig. 1).lsevier B.V. This is an open access article under the CC BY-NC-ND license
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In this prospective, non-comparative, interventional case
series, 76 eyes of 76 patients with PEX and concomitant
visually signiﬁcant cataract from January 2012 to February
2013 were included. All patients had been referred to Farabi
Eye Hospital, a university-based tertiary care center. The study
protocol was approved by the Ethics Committee of Tehran
University of Medical Sciences, and patients who agreed and
signed the informed consent form were enrolled.Inclusion and exclusion criteria
Pseudoexfoliation syndrome was diagnosed clinically as
presence of white ﬂuffy dandruff-like material on the pupillary
border, the lens capsule, or the angle. In patients with bilateral
disease, only the eye with more advanced cataract was
included in the study.
Patients with a history of ocular trauma or surgery, as well
as those with any other coexistent ocular disease including any
sign of glaucomatous optic neuropathy such as pathologic
optic disc cupping, neuroretinal rim notching, or asymmetric
cup to disc ratio (difference in cupping of 40.2) were
excluded from the study. Patients with severe phacodonesis
and subluxated lens, posterior synechiae, laser iridotomy, and
patients with posterior capsule rupture during the surgery were
also excluded. Only those who completed at least 6 months of
follow-up were included in the ﬁnal analysis (68 cases).Preoperative assessments
Preoperatively, a comprehensive ophthalmic examination
including slit lamp examination, Goldmann applanationFig. 1. Intraocular pressure trend during follow up periodtonometry, gonioscopy, dilated fundus examination, and visual
ﬁled evaluation were done for all patients. Patients demo-
graphics and baseline characteristics including age, gender,
Snellen chart best corrected visual acuity [converted to
logMAR unit (logMAR BCVA)], and central corneal thickness
(CCT), measured ultrasonically (Nidek UP-1000 Ultrasonic
Pachymeter), were recorded. All IOP measurements were
performed twice daily: once in the morning between 8 and
10 AM and the other in the evening between 6 and 8 PM. The
minimum and maximum IOP and the mean IOP were
recorded. Diurnal IOP variation was deﬁned as the difference
between maximum and minimum pressures.Surgical technique and follow-up method
All patients underwent phacoemulsiﬁcation by the same
surgeon (G.F.). Brieﬂy, under topical anesthesia and through a
3.2 mm-sized, temporal, clear-corneal incision, ocular viscoe-
lastic agent was injected into the anterior chamber (AC), and a
continuous curvilinear capsulorhexis was fashioned. There-
after, hydrodissection, using balance salt solution (BSS), was
done on a 25-gauge blunt needle. Phacoemulsiﬁcation was
then carried out, and a one-piece acrylic intraocular lens
(AcrySof SA60AT, Alcon Laboratories, Inc., Fort Worth,
TX) was implanted in the lens capsular bag. In the end, the
AC was reformed with BSS, and corneal incisions were made
watertight. Postoperatively, patients were given topical anti-
biotic and steroid eye drops, both of which were administered
four times a day for one week; the latter was tapered within
one month.
Follow-up examinations including IOP measurement were
done at postoperative day 1, week 1, month 1, month 3, and
month 6. More frequent visits were scheduled if needed based(mean 7 standard error). IOP = intraocular pressure.
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or condition was addressed accordingly.
Statistical analysis
Statistical analysis was performed using SPSS for Windows
version 16 (SPSS Inc, Chicago, IL). Results have been
reported as mean 7 standard deviation (SD) for quantitative
variables and as percentages for categorical variables. Paired
Student's t test was used for the evaluation of continuous
variable changes pre- and postoperatively. The Pearson Pro-
duct Moment Correlation Coefﬁcient was used to evaluate the
correlation between the two continuous variables. For all
measurements, a two-tailed test was used, and a p value of
o0.05 was considered signiﬁcant.
Results
A total of 68 eyes of 68 patients were analyzed. Patient
demographics and baseline characteristics are summarized in
Table 1.
The mean IOP dropped from 17.45 7 3.32 mm Hg (range
12.5–25.5) at baseline to 12.57 7 1.58 mm Hg (range 9–16)
at postoperative 6 months (p o 0.001). Mean IOP drop at
6 months was not correlated with age (r = 0.057, p = 0.643) or
CCT (r = 0.009, p = 0.944), but was moderately correlated
with the baseline Mean IOP (r = 0.601, p o 0.001).
The minimum and maximum IOP dropped from 14.97 7
3.46 mm Hg (range 10–23) and 20.03 7 3.39 (range 15–28)
at baseline to 11.53 7 1.79 mm Hg (range 9–16) and 13.01
7 1.81 (range 10–17) (p o 0.001 for both) at postoperative
6 months, respectively. The minimum IOP drop at 6 months
was not correlated with age (r = 0.071, p = 0.564) or CCT (r =
0.066, p = 0.594), but was strongly correlated with baseline
minimum IOP (r = 0.872, p o 0.001). Similarly, the
maximum IOP drop at 6 months was not correlated with age
(r =  0.068, p = 0.584) and CCT (r = 0.37, p = 0.765) but
was strongly correlated with baseline maximum IOP (r =
0.860, p o 0.001).Table 1
Patient demographics and baseline characteristics (n = 68).
Variablea Description




CCT 533.19 7 17.03 (485–573)
Mean IOP (mm Hg) 17.45 7 3.32 (12.5–25.5)
Minimum IOP (mm Hg) 16.69 7 3.91 (10–25)
Maximum IOP (mm Hg) 18.31 7 4.45 (11–28)
Diurnal IOP variation (mm Hg) 5.06 7 1.85 (2–10)
BCVA (LogMAR) 0.92 7 0.46 (0.5–2.2)
CCT: central corneal thickness; BCVA: best corrected visual acuity; IOP:
intraocular pressure; LogMAR: logarithm of minimal angle of resolution.
aAll numerical variables are presented as mean 7 standard deviation
(range), and categorical variables are presented as number (percent).Diurnal IOP variation dropped from 5.06 7 1.85 mm Hg
(range 2–10) at baseline to 1.49 7 0.93 mm Hg (range 0–4) at
postoperative 6 months (p o 0.001). This drop was not
correlated with age (r = 0.188, p = 0.124) or CCT (r =
0.151, p = 0.218), but was strongly correlated with baseline
diurnal IOP variation (r = 0.847, p o 0.001).
Discussion
Although cataract surgery has been shown to reduce baseline
IOP both in PEX and normal eyes,10–15 there are a few reports
about the effect of this procedure on diurnal IOP variations.
In our study there was a signiﬁcant IOP reduction in mean,
minimum, and maximum IOP in all post-operative visits (p-
value o 0.001 for all). We observed about 5 mm Hg
reduction in baseline mean IOP in eyes with PEX and
associated cataract at 6 months post cataract surgery follow-
up. Merkur et al. in a study have reported a similar amount of
IOP drop (4.52 mm Hg) after uneventful phacoemulsiﬁcation
in PEX patients in the same follow-up period.14 With a longer
follow-up, this IOP drop is less pronounced, but still sig-
niﬁcant.14,16 Many studies have reported greater IOP reduction
with cataract extraction in PEX eyes than those without this
pathology, with or without glaucoma.14,15,17
In the present study, both minimum and maximum IOP drop
and also diurnal IOP variation drop were positively correlated
with baseline respective values; the higher the baseline IOP or
diurnal IOP variation, the greater drop. Many previous studies
have also conﬁrmed this correlation in PEX eyes with or without
glaucoma13,16 as well as in non-PEX eyes either with or without
preoperative ocular hypertension18 or glaucoma.19 Therefore, it
can be inferred that crystalline lens plays a major role in IOP
elevation in all eyes, partly due to shallowing of the anterior
chamber, and hence, its removal results in a signiﬁcant IOP drop
with direct correlation with baseline IOP. Theoretically, removing
the thickened crystalline lens and replacing it with a thin IOL
should relieve some of the aqueous drainage impedance through
angle. Moreover, cataract extraction removes the anterior lens
capsule, which may be one of the main sources of exfoliative
material. It may also wash out the present PEX materials and
pigments from trabecular meshwork, hence enhancing aqueous
drainage in PEX patients.
High baseline IOP and high IOP ﬂuctuations are accepted as
risk factor for progression to exfoliative glaucoma.9,20 IOP and
its diurnal variation are usually higher than primary open-angle
glaucoma (POAG), and it has been shown that reduction of
both is more effective in PEX than POAG in preventing visual
ﬁeld damage,7 so controlling intraocular pressure is an
important issue to prevent glaucoma in these patients. It seems
that blockage of trabecular meshwork with PEX material and
pigment and the resultant trabecular cell dysfunction causes
IOP elevation in PEX syndrome.3
We observed signiﬁcant ﬂattening of diurnal IOP variation
in our patients following phacoemulsiﬁcation. In fact, none of
our patients had diurnal IOP variation of more than 5 mm Hg.
We had an average of 3.5 mm Hg reduction in mean diurnal
IOP variation at 6 month post cataract surgery which is
Z. Vahedian et al. / Journal of Current Ophthalmology 27 (2015) 12–15 15comparable to a report by Rao A.21 In this study, diurnal IOP
variation, as well as minimum, peak, and mean IOP were
signiﬁcantly less two months after cataract surgery in PEX
irrespective of preoperative anterior chamber depth. Therefore,
we can postulate that crystalline lens in PEX syndrome may be
one of the sources of IOP rise and ﬂuctuation with some
mechanisms other than changes in angle width. May be
vascular mechanism are also important in this regard. Vascular
involvement ad resultant ischemia in PEX,1,3,7 may cause
transient recurrent uveal congestion which may lead to more
reduced uveoscleral outﬂow at some times. Reduction in the
amount of PEX material production surgery possibly reduces
these ischemic changes and blunts IOP ﬂuctuations.
The importance of IOP ﬂuctuations in causing glaucomatous
damage in PEX cannot be overemphasized. As we found here,
cataract surgery can help ﬂatten the spikes in diurnal IOP.
Long-term follow-up is worth investigation in this regard.
Although cataract surgery signiﬁcantly reduces IOP and its
ﬂuctuation in PEX syndrome, it does not totally eliminate the
risk of glaucoma development. Shingleton et al. have observed
that 2.7% of PEX eyes without glaucoma will need to use
topical hypotensive agents approximately 3 years after pha-
coemulsiﬁcation.16 This fact, highlights the need for life-long
follow-up of these patients. In our study, however, the follow-
up was much shorter, none of patient's IOP exceeded 17 mm
Hg postoperatively, and none of them needed medication to
control their IOP. In a study by Altan et al., none of the
nonglaucomatous PEX eyes needed to be treated medically for
IOP elevation after phacoemulsiﬁcation during 32 months of
follow-up, which is, again, shorter than the follow-up period of
the Shingleton study.13
We did not ﬁnd any signiﬁcant relation between age and
post-operative IOP values. This ﬁnding is in accordance with
previous studies.16,21 There was also no signiﬁcant correlation
between CCT and post-operative IOP.
Eyes with intraoperative complications, such as zonular
dialysis and posterior capsular tear, were purposely excluded
from our study. These eyes may be more susceptible to
postoperative IOP spikes and glaucoma development and
could skew data analysis.
This study is one of the few assessing the effect of
phacoemulsiﬁcation on diurnal IOP variation in pseudoexfo-
liation syndrome, however, it has some limitations which
should be addressed. Most importantly, the follow-up time is
short, which precludes us to have any comments about long-
term IOP ﬂuctuations after cataract surgery. In addition, we
measured IOP 2 times a day for all patients, and we cannot be
sure of the exact maximum and minimum IOP values to
calculate the diurnal changes. More studies with more frequent
diurnal measurements are useful.
In conclusion, temporal clear corneal phacoemulsiﬁcation
without any additional intervention can be an attractive choice
in managing the IOP and its variations in pseudoexfoliation
patients even with elevated IOP who do not have advanced
optic nerve damage. This option is much simpler and less
prone to complications than other surgeries to control IOP. Atthe same time, the superior conjunctiva remains spared in case
future ﬁltration procedures become necessary.
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